Feladilimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Feladilimab, covering 2025-10-15 to 2025-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM [Phase 1, Phase 2]